With this launch, Neurally Adjusted Ventilatory Assist is now available for both neonatal and adult patients.
The findings also suggest possible new ways to treat lung diseases in humans.
HR 6376 seeks to allow other nonphysician practitioners, such as physician assistants and nurse practitioners, to supervise PR and cardiac programs.
The index allows clinical outcomes such as length-of-stay and mortality for surgical patients to be more accurately compared among hospitals.
The results of four different clinical trials were presented at last weeks North American Cystic Fibrosis Conference in Baltimore.
NAVA has been associated with improved patient-ventilator synchrony and lower peak airway pressure in neonatal and pediatric patient populations.
The findings of Inspire Pharmaceuticals phase 3 clinical trial will be presented today at the North American Cystic Fibrosis Conference.
The study finds that even as overall mortality rates at US hospitals have improved, an enormous gap between one- and five-star rated hospitals persists.
While several days of acute exposure to high level air pollution was a known risk factor for exacerbation of preexisting COPD, until now no studies linked long-term air pollution exposure to the development or progression of the disease.
The 1,500 adults surveyed cited concerns about side effects, exaggerated epidemic messages, and a desire to build up their own immune systems.